삼성바이오로직스

207940 코스피
788,000 4,000 (+0.51%)
기준 : 05/17
  • 시가총액
    560,851억
  • 주식수
    7,117만
  • PER
    62.64배
  • PBR
    5.60배
  • ROE
    8.94%
  • 결산월
    12월

24.1Q 업데이트 - 주요계정

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09 2019/06 2019/03 2018/12 2018/09 2018/06 2018/03 2017/12 2017/09 2017/06 2017/03 2016/12 2016/09 2016/06 2016/03 2015/12 2015/09 2015/06 2015/03 2014/12 2014/09 2014/06 2014/03 2013/12 2013/09 2013/06 2013/03 2012/12 2012/09
매출액(수익) 39,20539,205.7 36,94536,945.8 35,86635,866.0 34,25634,256.7 32,10932,109.1
내수 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 36,94536,945.8 35,86635,866.0 34,25634,256.7 32,10932,109.1
매출원가 20,40120,401.9 18,91818,918.2 18,50818,508.0 17,05517,055.1 16,29616,296.5
원재료 N/AN/A 7,9207,920.2 7,5537,553.8 6,8496,849.4 6,1416,141.8
재고자산의변동 N/AN/A -1,946-1,946.3 -1,445-1,445.5 -1,233-1,233.4 -1,097-1,097.8
기타원가 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
인건비 N/AN/A 4,6174,617.6 4,4424,442.1 4,2914,291.6 4,0654,065.9
감가상각비 N/AN/A 4,4554,455.3 3,9853,985.8 3,4563,456.1 3,2933,293.0
기타 N/AN/A 3,8713,871.2 3,9713,971.7 3,6913,691.3 3,8933,893.4
매출총이익 18,80318,803.7 18,02718,027.6 17,35717,357.9 17,20117,201.5 15,81215,812.5
판매비와관리비 7,3717,371.4 6,8906,890.8 6,5926,592.9 6,3746,374.4 5,8235,823.0
급여 N/AN/A 1,8061,806.6 1,7711,771.4 1,7291,729.4 1,5651,565.3
퇴직급여 N/AN/A 106106.9 106106.4 109109.7 103103.8
복리후생비 N/AN/A 405405.2 413413.5 411411.7 381381.9
임차료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수도광열비 N/AN/A 3737.2 3333.2 2929.2 2626.6
전산처리비 N/AN/A 228228.1 206206.9 215215.9 195195.7
지급수수료 N/AN/A 1,5581,558.9 1,3241,324.9 1,1821,182.2 1,0241,024.7
용역비 N/AN/A 2525.2 2222.9 1616.8 1616.8
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 119119.1 108108.3 109109.1 101101.7
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 815815.8 1,0501,050.7 839839.5 626626.1
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A 215215.1 9898.3 5252.2 164164.8
감가상각비 N/AN/A 219219.9 202202.5 197197.7 171171.9
무형자산상각비 N/AN/A 9999.7 9292.8 8989.0 8383.3
기타 N/AN/A 1,2521,252.5 1,1601,160.6 1,3911,391.4 1,3591,359.8
영업이익 11,43211,432.3 11,13611,136.8 10,76510,765.0 10,82710,827.1 9,9899,989.5
EBITDA N/AN/A 15,95715,957.1 15,98415,984.5 14,28014,280.6 13,76413,764.4
금융손익 N/AN/A 1919.5 839839.6 -343-343.5 -649-649.1
금융수익 2,1032,103.0 2,5182,518.9 1,9011,901.1 2,7912,791.5 3,1553,155.8
이자수익 N/AN/A 956956.5 904904.0 892892.0 802802.2
외환거래이익 N/AN/A 1,4741,474.6 1,1021,102.3 1,8441,844.9 2,2052,205.2
외환차익 N/AN/A 1,3091,309.8 1,3921,392.2 1,7591,759.1 1,8451,845.1
외화환산이익 N/AN/A 164164.8 -289-289.9 8585.8 360360.0
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A N/AN/A 6868.0 7575.5 7676.3
금융자산평가이익 N/AN/A N/AN/A -40-40.2 -10-10.5 44.5
파생상품이익 N/AN/A 8787.8 -132-132.9 -10-10.5 6767.5
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 1,9411,941.6 2,4992,499.4 1,0611,061.5 3,1353,135.0 3,8053,805.0
이자비용 N/AN/A 815815.9 867867.1 868868.6 828828.5
외환거래손실 N/AN/A 1,5861,586.5 135135.1 2,1712,171.8 2,9262,926.4
외환차손 N/AN/A 1,3741,374.5 1,5411,541.3 1,6611,661.3 1,3581,358.9
외화환산손실 N/AN/A 211211.9 -1,406-1,406.1 510510.4 1,5671,567.5
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A 00.0 44.4 0-0.3 N/AN/A
파생상품손실 N/AN/A 9797.0 5454.8 9494.1 4949.9
기타 N/AN/A 00.0 00.0 00.0 00.0
기타영업외손익 4343.1 4848.5 1818.9 -39-39.7 596596.7
기타영업외수익 123123.7 130130.9 8181.6 3131.7 666666.5
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A 00.0 00.0 0-0.1 00.0
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A 33.4 22.5 22.1 22.0
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A 5151.5 695695.7 645645.0 644644.1
유형,리스자산처분이익 N/AN/A 11.0 11.5 11.5 0-0.5
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A -644-644.1 -644-644.1 N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 7474.9 2525.9 2727.1 1919.6
기타영업외비용 8080.6 8282.4 6262.7 7171.4 6969.8
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A 2929.8 2626.6 2626.3 2626.2
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 3636.0 1010.5 1919.4 2020.3
무형자산처분손실 N/AN/A 33.6 11.6 11.6 77.2
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 1212.9 2323.9 2424.0 1515.9
종속기업및관계기업관련손익 -2-2.7 -4-4.9 -4-4.9 -3-3.9 134134.4
지분법손익 N/AN/A -4-4.9 -4-4.9 -3-3.9 134134.4
지분법이익 N/AN/A N/AN/A 22.2 11.2 137137.8
지분법손실 N/AN/A -4-4.9 -7-7.1 -5-5.2 -3-3.4
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A -4-4.9 -3-3.9 134134.4
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 11,63411,634.1 11,19911,199.8 11,61811,618.6 10,43910,439.9 10,07110,071.5
법인세비용 2,6812,681.1 2,6222,622.9 2,2492,249.4 2,1822,182.8 2,1422,142.8
중단사업이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
당기순이익 8,9528,952.9 8,5768,576.9 9,3699,369.1 8,2578,257.1 7,9287,928.6
지배지분 순이익 8,9528,952.9 8,5768,576.9 9,3699,369.1 8,2578,257.1 7,9287,928.6
비지배지분 순이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익 -114-114.7 -116-116.7 -14-14.9 5454.2 7575.5
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A -49-49.9 -49-49.7 0-0.2 1212.0
해외사업환산손익 N/AN/A 44.5 -9-9.5 22.3 1010.5
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A -71-71.4 4444.3 5151.6 5252.9
총포괄이익 8,8388,838.2 8,4608,460.1 9,3549,354.2 8,3118,311.4 8,0048,004.2
지배지분 총포괄이익 8,8388,838.2 8,4608,460.1 9,3549,354.2 8,3118,311.4 8,0048,004.2
비지배지분 총포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
주당순이익 N/AN/A 12,05012,050.6 13,16313,163.7 11,60111,601.3 11,16011,160.7
시가총액 N/AN/A 540,922540,922.4 484,694484,694.9 529,534529,534.5 560,851560,851.1
주가 N/AN/A 760,000760,000.0 681,000681,000.0 744,000744,000.0 788,000788,000.0
주가수익배수 N/AN/A 63.0763.07 51.7351.73 64.1364.13 70.7470.74

20년 재무제표를 한번에! 실적시즌 혜택! 지금 회원가입하면 종목 재무분석 매일 3건 무료! 회원가입

실적시즌! 종목 재무분석 매일 3건 무료! 회원가입